Caris Life Sciences (CAI) Stock Forecast, Price Target & Predictions
CAI Stock Forecast
Caris Life Sciences (CAI) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $34.00, with a high of $38.00 and a low of $26.00. This represents a 47.57% increase from the last price of $23.04.
CAI Stock Rating
Caris Life Sciences stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (77.78%), 2 Hold (22.22%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
CAI Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Caris Life Sciences | 47.57% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Biotech Stocks | 41.48% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 2 | 3 | 13 |
| Avg Price Target | $38.00 | $34.67 | $29.62 |
| Last Closing Price | $23.04 | $23.04 | $23.04 |
| Upside/Downside | 64.93% | 50.48% | 28.56% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Nov, 26 | 1 | 9 | 4 | - | - | 14 |
| Oct, 26 | 1 | 9 | 4 | - | - | 14 |
| Sep, 26 | 1 | 9 | 3 | - | - | 13 |
| Aug, 26 | 1 | 9 | 3 | - | - | 13 |
| Jul, 26 | 1 | 9 | 3 | - | - | 13 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 05, 2026 | UBS | $38.00 | $33.22 | 14.39% | 64.93% | |
| Oct 27, 2026 | BTIG | $38.00 | $32.46 | 17.07% | 64.93% | |
| Sep 09, 2026 | UBS | $28.00 | $24.82 | 12.81% | 21.53% | |
| Aug 07, 2026 | BTIG | $33.00 | $20.00 | 65.00% | 43.23% | |
| Aug 06, 2026 | Evercore ISI | $26.00 | $16.45 | 58.05% | 12.85% | |
| Jul 06, 2026 | Evercore ISI | $25.00 | $17.71 | 41.16% | 8.51% | |
| May 08, 2026 | Catherine Ramsey Schulte | Robert W. Baird | $22.00 | $15.97 | 37.76% | -4.51% |
| May 08, 2026 | Mark Massaro | BTIG | $32.00 | $19.84 | 61.29% | 38.89% |
| Apr 10, 2026 | Piper Sandler | $21.00 | $17.89 | 17.38% | -8.85% | |
| Feb 17, 2026 | Robert W. Baird | $26.00 | $20.62 | 26.09% | 12.85% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 05, 2026 | Cowen & Co. | Buy | Buy | hold |
| Oct 27, 2026 | BTIG | Buy | Buy | hold |
| Oct 13, 2026 | Cowen & Co. | Buy | Buy | hold |
| Sep 09, 2026 | UBS | Neutral | initialise | |
| Aug 07, 2026 | BTIG | Buy | Buy | hold |
| Aug 06, 2026 | Evercore ISI | Outperform | Outperform | hold |
| Jun 01, 2026 | Wolfe Research | Outperform | Peer Perform | downgrade |
| May 08, 2026 | New Street | Perform | initialise | |
| May 08, 2026 | BTIG | Buy | Buy | hold |
| Apr 10, 2026 | Piper Sandler | Neutral | initialise |
Financial Forecast
EPS Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | - | - | - | - | - |
| Avg Forecast | $5.71 | $-10.43 | - | $0.21 | $0.66 |
| High Forecast | $6.84 | $-10.43 | - | $0.39 | $0.85 |
| Low Forecast | $4.58 | $-10.43 | - | $0.03 | $0.29 |
| Surprise % | - | - | - | - | - |
Revenue Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | - | - | - | - | - |
| Avg Forecast | $421.94M | $452.50M | $330.09M | $939.25M | $1.16B |
| High Forecast | $506.33M | $452.50M | $330.09M | $939.25M | $1.16B |
| Low Forecast | $337.55M | $452.50M | $330.09M | $939.25M | $1.16B |
| Surprise % | - | - | - | - | - |
Net Income Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | - | - | - | - | - |
| Avg Forecast | $123.78M | $-187.27M | - | $3.77M | $10.23M |
| High Forecast | $148.53M | $-187.27M | - | $7.00M | $15.26M |
| Low Forecast | $99.02M | $-187.27M | - | $538.47K | $5.21M |
| Surprise % | - | - | - | - | - |